Integra LifeSciences Holdings (IART) — Cash Flow-to-Debt Ratio
Integra LifeSciences Holdings (IART) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of $40.91 Million could theoretically repay 0% of its total liabilities ($2.61 Billion) in one year. See cash generation quality of Integra LifeSciences Holdings to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Integra LifeSciences Holdings Cash Flow-to-Debt Ratio (1995–2024)
Historical debt coverage capacity for Integra LifeSciences Holdings across 30 annual periods. Also explore how fast is Integra LifeSciences Holdings growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Integra LifeSciences Holdings (1995–2024)
Year-by-year debt coverage analysis for Integra LifeSciences Holdings. For market capitalisation and broader financial context, see market cap of Integra LifeSciences Holdings.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | $129.38 Million | $2.49 Billion | ▼ -18.6% |
| 2023 | 0.06x | $139.96 Million | $2.19 Billion | ▼ -49.7% |
| 2022 | 0.13x | $264.47 Million | $2.09 Billion | ▼ -14.9% |
| 2021 | 0.15x | $312.43 Million | $2.10 Billion | ▲ +53.5% |
| 2020 | 0.10x | $203.83 Million | $2.10 Billion | ▼ -20.9% |
| 2019 | 0.12x | $231.43 Million | $1.89 Billion | ▲ +6.4% |
| 2018 | 0.12x | $199.68 Million | $1.73 Billion | ▲ +126.3% |
| 2017 | 0.05x | $114.54 Million | $2.25 Billion | ▼ -57.6% |
| 2016 | 0.12x | $116.41 Million | $968.29 Million | ▲ +30.2% |
| 2015 | 0.09x | $94.48 Million | $1.02 Billion | ▲ +1.6% |
| 2014 | 0.09x | $79.46 Million | $874.30 Million | ▼ -10.2% |
| 2013 | 0.10x | $53.27 Million | $526.05 Million | ▲ +11.4% |
| 2012 | 0.09x | $58.72 Million | $645.82 Million | ▼ -43.2% |
| 2011 | 0.16x | $104.33 Million | $651.47 Million | ▼ -21.5% |
| 2010 | 0.20x | $105.57 Million | $517.35 Million | ▼ -29.4% |
| 2009 | 0.29x | $143.24 Million | $495.22 Million | ▲ +172.6% |
| 2008 | 0.11x | $72.59 Million | $684.23 Million | ▲ +25.8% |
| 2007 | 0.08x | $47.03 Million | $557.58 Million | ▼ -62.7% |
| 2006 | 0.23x | $71.70 Million | $317.46 Million | ▼ -37.0% |
| 2005 | 0.36x | $56.85 Million | $158.61 Million | ▲ +36.9% |
| 2004 | 0.26x | $38.98 Million | $148.89 Million | ▲ +8.2% |
| 2003 | 0.24x | $34.83 Million | $144.00 Million | ▼ -79.5% |
| 2002 | 1.18x | $31.98 Million | $27.07 Million | ▲ +77.1% |
| 2001 | 0.67x | $15.70 Million | $23.53 Million | ▲ +540.3% |
| 2000 | -0.15x | $-4.96 Million | $32.73 Million | ▼ -271.5% |
| 1999 | 0.09x | $2.50 Million | $28.30 Million | ▲ +103.0% |
| 1998 | -2.97x | $-9.80 Million | $3.30 Million | ▲ +2.3% |
| 1997 | -3.04x | $-7.90 Million | $2.60 Million | ▲ +12.6% |
| 1996 | -3.48x | $-8.00 Million | $2.30 Million | ▼ -24.2% |
| 1995 | -2.80x | $-5.60 Million | $2.00 Million | — |